Nycomed, Glenmark Settle Feud Over Cutivate
Drugmaker Nycomed US Inc. reached a settlement in New York on Wednesday in its patent dispute with Glenmark Generics Ltd. that will block Glenmark from producing a generic version of Nycomed's...To view the full article, register now.
Already a subscriber? Click here to view full article